Nanostring
Acquired2 known investors
NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.
BiotechDeep TechHealthtechMedical Devices
Investors · 2
Competitors · 2
by search overlapGenomeweb18 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Oup15 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Companies competing with Nanostring for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Nanostring do?
- NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.
- Who are Nanostring's investors?
- Nanostring's investors include Aspect Ventures, Owl Capital.